
DarioHealth Corp. – NASDAQ:DRIO
DarioHealth Corp. stock price today
DarioHealth Corp. stock price monthly change
DarioHealth Corp. stock price quarterly change
DarioHealth Corp. stock price yearly change
DarioHealth Corp. key metrics
Market Cap | 27.95M |
Enterprise value | 66.29M |
P/E | -1.64 |
EV/Sales | 1.95 |
EV/EBITDA | 1.50 |
Price/Sales | 2.85 |
Price/Book | 1.20 |
PEG ratio | N/A |
EPS | -0.64 |
Revenue | 19.04M |
EBITDA | -56.89M |
Income | -18.59M |
Revenue Q/Q | -18.51% |
Revenue Y/Y | -28.57% |
Profit margin | 135.34% |
Oper. margin | -219.16% |
Gross margin | 31.9% |
EBIT margin | -219.16% |
EBITDA margin | -298.73% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeDarioHealth Corp. stock price history
DarioHealth Corp. stock forecast
DarioHealth Corp. financial statements
Jun 2023 | 6.15M | -16.58M | -269.59% |
---|---|---|---|
Sep 2023 | 3.51M | 16.90M | 480.5% |
Dec 2023 | 3.61M | -12.00M | -331.88% |
Mar 2024 | 5.75M | -6.91M | -120.13% |
Sep 2025 | 15M | -7.34M | -48.95% |
---|---|---|---|
Oct 2025 | 13.14M | -12.39M | -94.3% |
Dec 2025 | 12.7M | -3.16M | -24.96% |
Dec 2025 | 13.44M | -12.39M | -92.24% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 117159000 | 38.75M | 33.08% |
---|---|---|---|
Sep 2023 | 106505000 | 38.47M | 36.12% |
Dec 2023 | 96389000 | 38.24M | 39.68% |
Mar 2024 | 136964000 | 58.93M | 43.03% |
Jun 2023 | -9.63M | 4.17M | 19.43M |
---|---|---|---|
Sep 2023 | -8.64M | -281K | 204K |
Dec 2023 | -7.34M | -83K | 0 |
Mar 2024 | -13.11M | -8.85M | 20.20M |
DarioHealth Corp. alternative data
Nov 2023 | 390 |
---|---|
Mar 2024 | 472 |
Apr 2024 | 469 |
Sep 2024 | 460 |
DarioHealth Corp. Social Media Accounts
May 2025 | 7554 |
---|---|
Jul 2025 | 7519 |
Aug 2025 | 7505 |
Blood Glucose Monitoring System
1 Sep 2024 | 9 | 0 | 51 | 36 |
---|---|---|---|---|
8 Sep 2024 | 8 | 0 | 48 | 36 |
15 Sep 2024 | 8 | 0 | 71 | 31 |
22 Sep 2024 | 8 | 0 | 59 | 30 |
29 Sep 2024 | 8 | 0 | 59 | 30 |
6 Oct 2024 | 8 | 0 | 52 | 23 |
13 Oct 2024 | 8 | 0 | 51 | 24 |
20 Oct 2024 | 8 | 0 | 51 | 25 |
27 Oct 2024 | 7 | 0 | 55 | 22 |
3 Nov 2024 | 8 | 0 | 50 | 21 |
10 Nov 2024 | 8 | 0 | 54 | 23 |
17 Nov 2024 | 8 | 0 | 55 | 25 |
24 Nov 2024 | 8 | 0 | 58 | 26 |
1 Dec 2024 | 7 | 0 | 55 | 25 |
8 Dec 2024 | 8 | 0 | 57 | 29 |
15 Dec 2024 | 7 | 0 | 60 | 23 |
22 Dec 2024 | 7 | 0 | 57 | 22 |
29 Dec 2024 | 8 | 0 | 54 | 24 |
5 Jan 2025 | 7 | 0 | 55 | 23 |
12 Jan 2025 | 6 | 0 | 68 | 25 |
DarioHealth Focus
5 Feb 2023 | 72 | 7 | 9 |
---|---|---|---|
12 Feb 2023 | 72 | 6 | 9 |
19 Feb 2023 | 75 | 6 | 9 |
26 Feb 2023 | 73 | 7 | 10 |
5 Mar 2023 | 77 | 7 | 11 |
12 Mar 2023 | 77 | 7 | 11 |
19 Mar 2023 | 75 | 7 | 12 |
26 Mar 2023 | 75 | 8 | 12 |
2 Apr 2023 | 75 | 8 | 12 |
9 Apr 2023 | 77 | 8 | 11 |
16 Apr 2023 | 72 | 7 | 12 |
23 Apr 2023 | 75 | 7 | 11 |
30 Apr 2023 | 72 | 7 | 11 |
7 May 2023 | 69 | 6 | 10 |
14 May 2023 | 85 | 7 | 11 |
21 May 2023 | 82 | 7 | 12 |
28 May 2023 | 71 | 6 | 10 |
4 Jun 2023 | 74 | 6 | 11 |
11 Jun 2023 | 74 | 6 | 10 |
18 Jun 2023 | 68 | 6 | 10 |
Glucose Meter
5 Mar 2023 | 81 |
---|---|
12 Mar 2023 | 93 |
19 Mar 2023 | 85 |
26 Mar 2023 | 86 |
2 Apr 2023 | 79 |
9 Apr 2023 | 79 |
16 Apr 2023 | 83 |
23 Apr 2023 | 73 |
30 Apr 2023 | 80 |
7 May 2023 | 72 |
14 May 2023 | 73 |
21 May 2023 | 74 |
28 May 2023 | 73 |
4 Jun 2023 | 60 |
11 Jun 2023 | 72 |
18 Jun 2023 | 82 |
25 Jun 2023 | 74 |
2 Jul 2023 | 71 |
9 Jul 2023 | 72 |
16 Jul 2023 | 67 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
Aug 2023 | 26 |
---|---|
Sep 2023 | 33 |
Oct 2023 | 26 |
Nov 2023 | 22 |
Dec 2023 | 12 |
Jan 2024 | 12 |
Feb 2024 | 25 |
Apr 2024 | 27 |
May 2024 | 31 |
Jun 2024 | 33 |
Jul 2024 | 19 |
Aug 2023 | 241 |
---|---|
Sep 2023 | 241 |
Oct 2023 | 241 |
Nov 2023 | 241 |
Dec 2023 | 241 |
Jan 2024 | 241 |
Feb 2024 | 241 |
Mar 2024 | 241 |
Apr 2024 | 241 |
May 2024 | 276 |
Jun 2024 | 276 |
Jul 2024 | 276 |
DarioHealth Corp. other data
Period | Buy | Sel |
---|---|---|
Dec 2022 | 0 | 9872 |
Jan 2023 | 0 | 1200 |
May 2023 | 150 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | MATHEIS DENNIS director | Series B-2 Preferred Stock | 50 | $3.37 | $169 | ||
Purchase | SHAKED YOAV director | Series B-2 Preferred Stock | 40 | $3.37 | $135 | ||
Purchase | KAPLAN JON H. director | Series B-2 Preferred Stock | 30 | $3.37 | $101 | ||
Purchase | RAPHAEL EREZ director, officer.. | Series B-2 Preferred Stock | 30 | $3.37 | $101 | ||
Sale | RAPHAEL EREZ officer: Chief Ex.. | Common Stock | 1,200 | $6.21 | $7,450 | ||
Sale | MCGRATH DENNIS M director | Common Stock | 9,872 | $3.97 | $39,202 | ||
Sale | BACHER DROR officer: Chief Op.. | Common Stock | 804 | $19.09 | $15,349 | ||
Sale | RAPHAEL EREZ director, officer.. | Common Stock | 800 | $19.08 | $15,263 | ||
Sale | RAPHAEL EREZ director, officer.. | Common Stock | 200 | $19.05 | $3,810 | ||
Sale | BACHER DROR officer: Chief Op.. | Common Stock | 200 | $19.06 | $3,812 |
Quarter | Transcript |
---|---|
Q1 2024 15 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 28 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Erez Raphael (1973) Chief Executive Officer & Director | $665,860 |
Mr. Richard A. Anderson (1969) Pres & GM of North America | $430,590 |
Mr. Dror Bacher (1975) Chief Operating Officer | $248,630 |
Mr. Zvi Ben David (1961) Chief Financial Officer, Treasurer & Sec. | $170,650 |
-
What's the price of DarioHealth Corp. stock today?
One share of DarioHealth Corp. stock can currently be purchased for approximately $0.43.
-
When is DarioHealth Corp.'s next earnings date?
Unfortunately, DarioHealth Corp.'s (DRIO) next earnings date is currently unknown.
-
Does DarioHealth Corp. pay dividends?
No, DarioHealth Corp. does not pay dividends.
-
How much money does DarioHealth Corp. make?
DarioHealth Corp. has a market capitalization of 27.95M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 26.41% to 20.35M US dollars.
-
What is DarioHealth Corp.'s stock symbol?
DarioHealth Corp. is traded on the NASDAQ under the ticker symbol "DRIO".
-
What is DarioHealth Corp.'s primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of DarioHealth Corp.?
Shares of DarioHealth Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are DarioHealth Corp.'s key executives?
DarioHealth Corp.'s management team includes the following people:
- Mr. Erez Raphael Chief Executive Officer & Director(age: 52, pay: $665,860)
- Mr. Richard A. Anderson Pres & GM of North America(age: 56, pay: $430,590)
- Mr. Dror Bacher Chief Operating Officer(age: 50, pay: $248,630)
- Mr. Zvi Ben David Chief Financial Officer, Treasurer & Sec.(age: 64, pay: $170,650)
-
How many employees does DarioHealth Corp. have?
As Jul 2024, DarioHealth Corp. employs 276 workers, which is 15% more then previous quarter.
-
When DarioHealth Corp. went public?
DarioHealth Corp. is publicly traded company for more then 9 years since IPO on 14 Mar 2016.
-
What is DarioHealth Corp.'s official website?
The official website for DarioHealth Corp. is mydario.com.
-
Where are DarioHealth Corp.'s headquarters?
DarioHealth Corp. is headquartered at 18 West 18th Street, New York, NY.
-
How can i contact DarioHealth Corp.?
DarioHealth Corp.'s mailing address is 18 West 18th Street, New York, NY and company can be reached via phone at 833 914 3796.
DarioHealth Corp. company profile:

DarioHealth Corp.
mydario.comNASDAQ
276
Medical - Diagnostics & Research
Healthcare
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
New York, NY 10011
CIK: 0001533998
ISIN: US23725P2092
CUSIP: 23725P209